From: Active enhancers: recent research advances and insights into disease
Type | Method | Description | References |
---|---|---|---|
Chromatin features and histone modifications | ChIP-seq, CUT&RUN, CUT&Tag | Can be used to screen putative enhancers in the genome-wide and identify active enhancers. Study chromatin regulation and identify the genome-wide binding sites of specific TFs. CUT&RUN and CUT&Tag, as upgrades of ChIP, requires few cells, CUT&Tag is for single cell | |
Chromatin accessibility | ATAC-seq, DNase-seq, MNase-seq, FAIRE-seq | Genome-wide annotation of regulatory regions based on chromatin accessibility for screening of potential enhancers and transcription factors. MNase-seq is a method that reflects chromatin accessibility indirectly, and the other three methods reflect chromatin accessibility directly | [83] |
Transcriptional assays | RNA-seq, CAGE, GRO-seq | Annotation of active enhancers by eRNA expression levels generated by enhancer transcription. CAGE and GRO-seq methods improved the sequencing sensitivity | |
Massively parallel reporter assays | MPRA, STARR-seq | Can be used to readout enhancer activity on a large scale and understand the functional sequence of enhancers in depth | |
Chromosome conformation assays | Hi-C, ChIA-PET, HiChIP | Can be widely used to explore enhancer-promoter connections from the 3D architecture of chromosomes and identify target genes of enhancers | |
CRISPR system | CRISPR screens, CRISPR/Cas9, CRISPRa, CRISPRi | A high-throughput tool for reading out functional enhancers using CRISPR screens. Functional annotation of potential enhancers and analysis of regulatory mechanisms can be performed using CRISPR/Cas9 and its derivative technologies | |
Oligonucleotide method | LNAs | Targeting eRNA to inhibit enhancer activity | [127] |